[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FI870693A0 - Cukloalkano(1,2-b)indolsulfonamider. - Google Patents

Cukloalkano(1,2-b)indolsulfonamider.

Info

Publication number
FI870693A0
FI870693A0 FI870693A FI870693A FI870693A0 FI 870693 A0 FI870693 A0 FI 870693A0 FI 870693 A FI870693 A FI 870693A FI 870693 A FI870693 A FI 870693A FI 870693 A0 FI870693 A0 FI 870693A0
Authority
FI
Finland
Prior art keywords
indolsulfonamider
cukloalkano
Prior art date
Application number
FI870693A
Other languages
English (en)
Other versions
FI870693A (fi
FI86544C (fi
FI86544B (fi
Inventor
Horst Boeshagen
Ulrich Rosentreter
Folker Lieb
Hermann Oediger
Friedel Seuter
Elisabeth Perzborn
Volker-Bernd Fiedler
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of FI870693A0 publication Critical patent/FI870693A0/fi
Publication of FI870693A publication Critical patent/FI870693A/fi
Application granted granted Critical
Publication of FI86544B publication Critical patent/FI86544B/fi
Publication of FI86544C publication Critical patent/FI86544C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/86—Carbazoles; Hydrogenated carbazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/56—Ring systems containing three or more rings
    • C07D209/80—[b, c]- or [b, d]-condensed
    • C07D209/82—Carbazoles; Hydrogenated carbazoles
    • C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Indole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI870693A 1986-02-21 1987-02-19 Foerfarande foer framstaellning av terapeutiskt aktiva cykloalkano/1,2-b/indolsulfonamidderivat och vid foerfarandet som mellanprodukter anvaendbara bensensulfonamidoalkylcykloalkano/1,2-b/indolderivat. FI86544C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE3605566 1986-02-21
DE3605566 1986-02-21
DE3631824 1986-09-19
DE19863631824 DE3631824A1 (de) 1986-02-21 1986-09-19 Cycloalkano(1.2-b)indol-sulfonamide

Publications (4)

Publication Number Publication Date
FI870693A0 true FI870693A0 (fi) 1987-02-19
FI870693A FI870693A (fi) 1987-08-22
FI86544B FI86544B (fi) 1992-05-29
FI86544C FI86544C (fi) 1992-09-10

Family

ID=25841196

Family Applications (1)

Application Number Title Priority Date Filing Date
FI870693A FI86544C (fi) 1986-02-21 1987-02-19 Foerfarande foer framstaellning av terapeutiskt aktiva cykloalkano/1,2-b/indolsulfonamidderivat och vid foerfarandet som mellanprodukter anvaendbara bensensulfonamidoalkylcykloalkano/1,2-b/indolderivat.

Country Status (19)

Country Link
US (3) US4827032A (fi)
EP (1) EP0242518B1 (fi)
JP (1) JPH075552B2 (fi)
KR (2) KR940007302B1 (fi)
AU (1) AU595855B2 (fi)
CA (1) CA1309414C (fi)
CS (1) CS275837B6 (fi)
DE (2) DE3631824A1 (fi)
DK (1) DK167009B1 (fi)
ES (1) ES2028801T3 (fi)
FI (1) FI86544C (fi)
GR (1) GR3001763T3 (fi)
HU (1) HU198686B (fi)
IE (1) IE59470B1 (fi)
IL (1) IL81611A (fi)
NO (1) NO171633C (fi)
NZ (1) NZ219319A (fi)
PH (1) PH24491A (fi)
PT (1) PT84316B (fi)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3826371A1 (de) * 1988-08-03 1990-02-08 Bayer Ag Tetrahydro-1-benz-(c,d)-indolpropionsaeure-sulfonamide
DE3829455A1 (de) * 1988-08-31 1990-03-15 Boehringer Mannheim Gmbh Sulfonamidoalkyl-cyclohexan-verbindungen, verfahren zu ihrer herstellung sowie arzneimittel
US5070099A (en) * 1988-10-31 1991-12-03 E. R. Squibb & Sons, Inc. Arylthioalkylphenyl carboxylic acids, derivatives thereof, compositions containing same method of use
US4959383A (en) * 1988-10-31 1990-09-25 E. R. Squibb & Sons, Inc. Phenylsulfone alkenoic acids, derivatives thereof, compositions containing same and method of use
US5006542A (en) * 1988-10-31 1991-04-09 E. R. Squibb & Sons, Inc. Arylthioalkylphenyl carboxylic acids, derivatives thereof, compositions containing same and method of use
GB8924392D0 (en) * 1989-10-30 1989-12-20 Bayer Ag Substituted cycloalkano/b/dihydroindole-and-indolesulphonamides
GB9008108D0 (en) * 1990-04-10 1990-06-06 Bayer Ag Cycloalkano(b)dihydroindoles and-indolesulphonamides substituted by heterocycles
DE4027278A1 (de) * 1990-08-29 1992-03-05 Bayer Ag Heterocyclisch substituierte indolsulfonamide
US5827871A (en) * 1991-06-26 1998-10-27 Smithkline Beecham Plc Medicaments 1,2,3,4-tetrahydrocarbazoles and 5-HT1 agonist use thereof
DE4131346A1 (de) * 1991-09-20 1993-03-25 Bayer Ag Indolsulfonamid substituierte dihydropyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
EP0603432B1 (en) * 1992-12-18 1998-10-21 Smithkline Beecham Plc Tetrahydrocarbazole derivatives for the manufacture of a medicament for the treatment of a disease where a 5-HT1-like agonist is indicated
DE19507751A1 (de) * 1995-03-06 1996-09-12 Bayer Ag Verfahren zur Herstellung von substituierten 1,2,3,4-Tetrahydrocarbazolen
US5708187A (en) * 1996-06-27 1998-01-13 Eli Lilly And Company 6-substituted-1,2,3,4-tetrahydro-9H-carbazoles and 7-substituted-10H-cyclohepta 7,6-B!indoles: New 5-HT1F agonists
DE19757983A1 (de) * 1997-12-24 1999-07-01 Bayer Yakuhin Ltd Thermodynamisch stabile Form von (r)-3[[(4-Fluorophenyl)sulfonyl]amino]-1,2,3,4-tetrahydro-9H-carbazol-0-propansäure (Ramatroban)
EP1915372B1 (en) * 2005-08-12 2013-11-20 Merck Canada Inc. Indole derivatives as crth2 receptor antagonists
US7662831B2 (en) * 2006-07-27 2010-02-16 Wyeth Llc Tetracyclic indoles as potassium channel modulators
US7601856B2 (en) * 2006-07-27 2009-10-13 Wyeth Benzofurans as potassium ion channel modulators
BRPI0715179A2 (pt) 2006-08-07 2013-06-11 Actelion Pharmaceuticals Ltd composto, composiÇço farmacÊutica e uso de um composto
GB0624084D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril amino acid salts
GB0624090D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril amine salts
GB0624087D0 (en) * 2006-12-01 2007-01-10 Selamine Ltd Ramipril combination salt
ATE543501T1 (de) * 2006-12-20 2012-02-15 Cardoz Ab Kombination von pemirolast und ramatroban zur verwendung bei der behandlung von entzündlichen erkrankungen
AU2007344274A1 (en) * 2007-01-16 2008-07-24 Cardoz Ab New combination for use in the treatment of inflammatory disorders
WO2009007674A2 (en) * 2007-07-11 2009-01-15 Cardoz Ab Combination for use in the treatment of atherosclerosis comprising a mast cell inhibitor and ramatroban or seratrodast
EP2300425A4 (en) * 2008-06-24 2012-03-21 Panmira Pharmaceuticals Llc PROSTAGLANDIN D2 RECEPTOR CYCLOALCANEÝBINDLUCK ANTAGONISTS
WO2010006939A1 (en) * 2008-07-15 2010-01-21 F. Hoffmann-La Roche Ag Aminotetrahydroindazoloacetic acids
CN102216249A (zh) 2008-11-17 2011-10-12 霍夫曼-拉罗奇有限公司 萘乙酸
SG171734A1 (en) 2008-11-17 2011-07-28 Hoffmann La Roche Naphthylacetic acids
CA2739725A1 (en) 2008-11-17 2010-05-20 F. Hoffmann-La Roche Ag Naphthylacetic acids used as crth2 antagonists or partial agonists
NZ603108A (en) 2010-03-22 2014-05-30 Actelion Pharmaceuticals Ltd 3-(heteroaryl-amino)-1,2,3,4-tetrahydro-9h-carbazole derivatives and their use as prostaglandin d2 receptor modulators
PL2697223T3 (pl) 2011-04-14 2017-01-31 Actelion Pharmaceuticals Ltd. Pochodne kwasu 7-(heteroaryloamino)-6,7,8,9-tetrahydropirydo[1,2-a]indolooctowego i ich zastosowanie jako modulatorów receptora prostaglandyny D2
US8470884B2 (en) 2011-11-09 2013-06-25 Hoffmann-La Roche Inc. Alkenyl naphthylacetic acids
MY179356A (en) 2014-03-17 2020-11-05 Idorsia Pharmaceuticals Ltd Azaindole acetic acid derivatives and their use as prostaglandin d2 receptor modulators
CN106103437A (zh) 2014-03-18 2016-11-09 埃科特莱茵药品有限公司 氮杂吲哚乙酸衍生物及其作为前列腺素d2受体调节剂的用途
EP4420734A3 (en) 2015-02-13 2024-11-06 Institut National de la Santé et de la Recherche Médicale Ptgdr-1 and/or ptgdr-2 antagonists for preventing and/or treating systemic lupus erythematosus
CA2993893A1 (en) 2015-09-15 2017-03-23 Idorsia Pharmaceuticals Ltd Crystalline forms

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1415322A (fr) * 1963-12-09 1965-10-22 Eastman Kodak Co Nouveaux composés de 3-sulfamidocyclobutanone et de 3-sulfamidocyclobutanol
US3642816A (en) * 1967-08-10 1972-02-15 Sterling Drug Inc 3-acetamido-1 2 3 4-tetrahydrocarbazole
JPS4713658Y1 (fi) * 1969-12-18 1972-05-18
CH586678A5 (fi) * 1970-05-25 1977-04-15 Hoffmann La Roche
DE2226702A1 (de) * 1972-05-25 1973-12-13 Schering Ag Neue mittel zur behandlung des diabetes mellitus
JPS5186117A (en) * 1975-01-27 1976-07-28 Tanabe Seiyaku Co Johoseibiryushiseizainoseiho
US4235901A (en) * 1978-05-08 1980-11-25 American Home Products Corporation 1-Hydroxyalkanamine pyrano(3,4-b)indole compositions and use thereof

Also Published As

Publication number Publication date
EP0242518B1 (de) 1991-04-10
FI870693A (fi) 1987-08-22
CA1309414C (en) 1992-10-27
PT84316A (en) 1987-03-01
IE870439L (en) 1987-08-21
KR940007302B1 (ko) 1994-08-12
EP0242518A1 (de) 1987-10-28
ES2028801T3 (es) 1992-07-16
NO171633B (no) 1993-01-04
US4827032A (en) 1989-05-02
PT84316B (pt) 1989-09-14
KR890001982A (ko) 1989-04-07
DK87187D0 (da) 1987-02-20
AU595855B2 (en) 1990-04-12
DK167009B1 (da) 1993-08-16
JPH075552B2 (ja) 1995-01-25
DK87187A (da) 1987-08-22
DE3631824A1 (de) 1988-03-31
FI86544C (fi) 1992-09-10
US4904797A (en) 1990-02-27
KR960001914B1 (en) 1996-02-06
US4965258A (en) 1990-10-23
IE59470B1 (en) 1994-03-09
KR870007885A (ko) 1987-09-22
GR3001763T3 (en) 1992-11-23
AU6880887A (en) 1987-08-27
PH24491A (en) 1990-07-18
NO171633C (no) 1993-04-14
NO870437D0 (no) 1987-02-04
NO870437L (no) 1987-08-24
DE3769191D1 (de) 1991-05-16
IL81611A (en) 1991-03-10
HU198686B (en) 1989-11-28
HUT44493A (en) 1988-03-28
FI86544B (fi) 1992-05-29
NZ219319A (en) 1990-12-21
CS8701093A2 (en) 1990-11-14
CS275837B6 (en) 1992-03-18
JPH0592954A (ja) 1993-04-16

Similar Documents

Publication Publication Date Title
DE3769191D1 (de) Cycloalkano(1,2-b)indol-sulfonamide.
LV5742B4 (lv) 3,5-divalizvietoti pirokatehina atvasinajumi
FI873584A0 (fi) Mjuk, sockerfri, poroes soetsaks- resp. bakverkssammansaettning.
DE3764686D1 (de) N,n'-dihalo-2-imidazolidinone.
DE3783669D1 (de) Alpha-aryl-alpha-phenethyl-1h-1,2,4-triazol-1-propan-nitrile.
FI884892A (fi) Tippbar slaepvagn foer motorfordon, speciellt personbilar.
FI872594A (fi) Cementprodukter, vilka innehaoller ytbehandlade oorganiska partiklar.
FI875619A (fi) 6-benzoxazinyl- och 6-benzotiazonyl-2,3,4,5-tetrahydropyridazin-3-oner.
DE3763411D1 (de) 1,2,3,6-tetrahydro-5-nitro-pyrimidin-derivate.
FI881322A (fi) Haestsko, skaerskilt foer travhaestar.
FI874428A (fi) Foerfarande foer framstaellning av vinylklorid medelst termisk spjaelkning av 1,2-dikloretan.
FI872267A (fi) Stabila, vattenhaltiga suspensionskoncentratkompositioner.
FI874864A (fi) Oformade, eldfasta massor.
DE3765646D1 (de) 2,5,6,7-tetranor-4,8-inter-m-phenylen-pgi2-derivate.
FI872598A (fi) N-1h-tetrazol-5-yl-2-tiofen-, n-1h -tetrazol-5-yl-2-pyrrol- och n-1h-tetrazol-5-yl-2-furankarboxamider.
DE3766518D1 (de) Substituierte 1,3,4,9-tetrahydropyrano(3,4-b)indol-1-acetate.
DE3788163D1 (de) 1,3,5-Trithian-Derivate.
FI871432A0 (fi) Foerkopplingsdrossel, speciellt foer gasurladdningslampor.
FI874479A (fi) Golvskoetselanordning, speciellt munstycke foer dammsugare.
FI875128A0 (fi) Kabelmuff, isynnerhet en intagningskabelmuff foer partraods intagningskabel.
FI870924A (fi) Aromatiska -alkylimino-tetrahydro-6h -1,3-tiazin-6-onderivater.
DE3761091D1 (de) 2,6-dimethyl-p-benzochinontetraalkylketale.
ATE62477T1 (de) Cycloalkano(1,2-b>indol-sulfonamide.
ATE58901T1 (de) Substituierte 1,3,4,9-tetrahydropyrano(3,4b>indol-1-acetate.
DE3770251D1 (de) 1,1,2-triaryl-1-buten-derivate.

Legal Events

Date Code Title Description
FG Patent granted

Owner name: BAYER YAKUHIN, LTD

MA Patent expired